Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2004 2
2005 2
2006 1
2007 1
2008 4
2009 4
2010 1
2011 3
2012 3
2013 3
2014 3
2015 1
2016 1
2017 1
2018 5
2019 2
2020 2
2021 5
2022 4
2023 8
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01.
Soran A, Ozmen V, Ozbas S, Karanlik H, Muslumanoglu M, Igci A, Canturk Z, Utkan Z, Ozaslan C, Evrensel T, Uras C, Aksaz E, Soyder A, Ugurlu U, Col C, Cabioglu N, Bozkurt B, Uzunkoy A, Koksal N, Gulluoglu BM, Unal B, Atalay C, Yıldırım E, Erdem E, Salimoglu S, Sezer A, Koyuncu A, Gurleyik G, Alagol H, Ulufi N, Berberoglu U, Dulger M, Cengiz O, Sezgin E, Johnson R. Soran A, et al. Among authors: igci a. Ann Surg Oncol. 2018 Oct;25(11):3141-3149. doi: 10.1245/s10434-018-6494-6. Epub 2018 May 17. Ann Surg Oncol. 2018. PMID: 29777404 Clinical Trial.
Primary Surgery with Systemic Therapy in Patients with de Novo Stage IV Breast Cancer: 10-year Follow-up; Protocol MF07-01 Randomized Clinical Trial.
Soran A, Ozmen V, Ozbas S, Karanlik H, Muslumanoglu M, Igci A, Canturk NZ, Utkan Z, Evrensel T, Sezgin E; MF07-01 Study Group. Soran A, et al. Among authors: igci a. J Am Coll Surg. 2021 Dec;233(6):742-751.e5. doi: 10.1016/j.jamcollsurg.2021.08.686. Epub 2021 Sep 13. J Am Coll Surg. 2021. PMID: 34530124 Clinical Trial.
Esophageal transection.
Özçınar B, Peker KD, Demirel S, Yanar F, Tuncer K, İğci A. Özçınar B, et al. Among authors: igci a. Ulus Cerrahi Derg. 2016 Dec 1;32(4):281-284. doi: 10.5152/UCD.2016.3232. eCollection 2016. Ulus Cerrahi Derg. 2016. PMID: 28149126 Free PMC article.
High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer.
Mollavelioglu B, Cetin Aktas E, Cabioglu N, Abbasov A, Onder S, Emiroglu S, Tükenmez M, Muslumanoglu M, Igci A, Deniz G, Ozmen V. Mollavelioglu B, et al. Among authors: igci a. World J Surg Oncol. 2022 Oct 21;20(1):349. doi: 10.1186/s12957-022-02810-z. World J Surg Oncol. 2022. PMID: 36271406 Free PMC article.
Metaplastic Breast Cancer: Mesenchymal Subtype Has Worse Survival Outcomes.
Özkurt E, Emiroğlu S, Cabioğlu N, Karanlık H, Önder S, Tükenmez M, İğci A, Özmen V, Müslümanoğlu M. Özkurt E, et al. Among authors: igci a. Breast Care (Basel). 2022 Dec;17(6):554-560. doi: 10.1159/000525324. Epub 2022 Jun 2. Breast Care (Basel). 2022. PMID: 36590148 Free PMC article.
Favorable Long-Term Outcome in Male Breast Cancer.
Özkurt E, Tükenmez M, Yılmaz R, Cabioğlu N, Müslümanoğlu M, Dinççağ AS, İğci A, Özmen V. Özkurt E, et al. Among authors: igci a. Eur J Breast Health. 2018 Jul 1;14(3):180-185. doi: 10.5152/ejbh.2018.3946. eCollection 2018 Jul. Eur J Breast Health. 2018. PMID: 30123885 Free PMC article.
Long-term outcomes and predictors of recurrence in node-negative early stage breast cancer patients.
Dogan I, Aydin E, Khanmammadov N, Paksoy N, Ferhatoğlu F, Ak N, Emiroglu S, Ibis K, Onder S, Tukenmez M, Cabioglu N, Kucucuk S, Muslumanoğlu M, Ozmen V, Saip P, Igci A, Aydiner A. Dogan I, et al. Among authors: igci a. J Cancer Res Clin Oncol. 2023 Nov;149(16):14833-14841. doi: 10.1007/s00432-023-05276-y. Epub 2023 Aug 18. J Cancer Res Clin Oncol. 2023. PMID: 37594533
55 results